EUGENIE CHETANGIE: Open Payments
NPI 1447859848 · HACKETTSTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 42 payments from 18 companies in 2025. Trend: 2023 $387 · 2024 $661 · 2025 $822
Food & beverage: $727Education: $95
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 10 | $264 |
| AstraZeneca Pharmaceuticals LP | 7 | $119 |
| Incyte Corporation | 3 | $51 |
| Karyopharm Therapeutics Inc. | 3 | $50 |
| Adaptive Biotechnologies Corporation | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Genentech USA, Inc. | 1 | $20 |
Products named: ENHERTU, JAKAFI, XPOVIO, clonoSEQ, Nubeqa, LYNPARZA, Itovebi, VERZENIO.
Industry payments across NJ — which companies pay providers there.
